首个国家级炎症性肠病标杆项目启动

Core Insights - The "Inflammatory Bowel Disease (IBD) Standardized Diagnosis and Management Capacity Improvement Project" has been launched as the first systematic initiative in the field of IBD treatment in China, aiming to enhance the uniformity of IBD diagnosis and treatment across the country [1] - IBD, which includes Ulcerative Colitis (UC) and Crohn's Disease (CD), is increasingly prevalent among the young adult population in China, with the number of patients expected to reach 1.5 million by 2025 [1] - There is a significant shortage of specialized IBD doctors in China, with only approximately 1,000 specialists available to meet the growing patient demand [1] Implementation Path - The project will establish standardized documents such as unified diagnosis and treatment pathways and discipline construction details to address inconsistencies in treatment processes [2] - A dual-track training system will be implemented to enhance the diagnostic capabilities of both grassroots doctors and senior specialists through mutual learning opportunities [2] - The project aims to unify assessment and evaluation standards for doctors, promoting talent development through a national, provincial, and tertiary cooperative evaluation mechanism [2] Project Goals - The project plans to complete the formulation of the "Standardized Diagnosis and Treatment Guidelines for Inflammatory Bowel Disease" and the talent training and evaluation system by the end of this year [3] - It aims to achieve evaluations for 20 units and 600 talents as part of its implementation [3]